Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.239 USD | +1.92% | -12.36% | -0.13% |
Apr. 01 | Transcript : Yield10 Bioscience, Inc., Q4 2023 Earnings Call, Apr 01, 2024 | |
Apr. 01 | Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 2.25M | Sales 2025 * | 4M | Capitalization | 3.68M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -13M | EV / Sales 2024 * | 1.64 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.92 x |
P/E ratio 2024 * |
-0.32
x | P/E ratio 2025 * |
-0.28
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.39% |
Latest transcript on Yield10 Bioscience, Inc.
1 day | +1.92% | ||
1 week | -12.36% | ||
Current month | -37.11% | ||
1 month | -33.61% | ||
3 months | +23.83% | ||
6 months | -32.29% | ||
Current year | -0.13% |
Managers | Title | Age | Since |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 07-12-31 |
Kristi Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 96-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 06-09-30 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 17-03-01 |
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.239 | +1.92% | 274,843 |
24-04-24 | 0.2345 | -8.75% | 1,103,880 |
24-04-23 | 0.257 | -1.53% | 373,783 |
24-04-22 | 0.261 | +2.35% | 378,266 |
24-04-19 | 0.255 | -6.49% | 296,103 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.13% | 3.68M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- YTEN Stock